1. Pathological examination of factors involved in PD-L1 expression in patients with oral tongue squamous cell carcinoma
- Author
-
Yu Koyama, Chiharu Ogawa, Chihiro Kurihara, Nao Hashimoto, Shota Shinagawa, Hiroya Okazaki, Takumi Koyama, Keisuke Sugahara, and Akira Katakura
- Subjects
PD-L1 ,CAFs ,α-SMA ,p53 ,Oral squamous cell carcinoma ,Dentistry ,RK1-715 ,Surgery ,RD1-811 - Abstract
Abstract Background Tumor tissues comprise cancer cells and stromal cells, and their interactions form the cancer microenvironment. Therefore, treatments targeting cells other than cancer cells are also actively being developed, and among them, treatment targeting PD-1, an immune checkpoint molecule that is important in tumor immune evasion, has also been indicated for head and neck cancer. PD-L1, a ligand of PD-1, is expressed in both tumor cells and stromal cells, and the scoring system based on the combined positivity rates of both types of cells, the combined positive score (CPS), is used for predicting treatment effect. However, much is unknown regarding the expression of PD-L1. In this study, we histopathologically examined factors controlling the expression of PD-1/PD-L1. This study included 37 patients who underwent resection surgery for tongue squamous cell carcinoma in the Department of Oral and Maxillofacial Surgery at Tokyo Dental College Suidobashi Hospital. The expression levels of PD-L1, α-SMA, and p53 were assessed by immunohistochemical staining. Results Seven participants had CPS ≥ 20, twenty-four participants had 1 ≤ CPS
- Published
- 2024
- Full Text
- View/download PDF